April 2nd 2025
Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Ongoing Analytical Procedure Performance Verification—Stage 3 of USP<1220>
Analytical procedure performance can be continually verified by risk-based monitoring of performance related data.